US5112824A
(en)
|
1989-12-08 |
1992-05-12 |
Merck & Co., Inc. |
Benzofuran compounds as class III antiarrhythmic agents
|
FR2665159B1
(fr)
|
1990-07-24 |
1992-11-13 |
Rhone Poulenc Sante |
Nouveaux derives de la pyridine et de la quinoleine, leur preparation et les compositions pharmaceutiques qui les contiennent.
|
DE4212748A1
(de)
|
1992-04-16 |
1993-10-21 |
Thomae Gmbh Dr K |
Benzimidazole, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
|
GB9420521D0
(en)
|
1994-10-12 |
1994-11-30 |
Smithkline Beecham Plc |
Novel compounds
|
GB9420999D0
(en)
|
1994-10-18 |
1994-12-07 |
Smithkline Beecham Plc |
Novel compounds
|
AU4515896A
(en)
|
1994-12-12 |
1996-07-03 |
Merck & Co., Inc. |
Substituted 2-acylamino-pyridines as inhibitors of nitric oxide synthase
|
GB9500580D0
(en)
|
1995-01-12 |
1995-03-01 |
Merck Sharp & Dohme |
Therapeutic agents
|
CN1151147C
(zh)
|
1995-02-02 |
2004-05-26 |
史密丝克莱恩比彻姆有限公司 |
作为5-ht受体拮抗剂的吲哚衍生物
|
US5668148A
(en)
|
1995-04-20 |
1997-09-16 |
Merck & Co., Inc. |
Alpha1a adrenergic receptor antagonists
|
GB9517559D0
(en)
|
1995-08-26 |
1995-10-25 |
Smithkline Beecham Plc |
Novel compounds
|
US5886186A
(en)
|
1995-10-25 |
1999-03-23 |
Versicor, Inc. |
Synthesis of substituted N-heteroaromatic compounds and methods of use thereof
|
JP2000507590A
(ja)
|
1996-04-03 |
2000-06-20 |
メルク エンド カンパニー インコーポレーテッド |
ファルネシル―タンパク質トランスフェラーゼ阻害剤
|
US5872136A
(en)
|
1996-04-03 |
1999-02-16 |
Merck & Co., Inc. |
Arylheteroaryl inhibitors of farnesyl-protein transferase
|
FR2763944B1
(fr)
|
1997-06-03 |
2000-12-15 |
Centre Nat Rech Scient |
Nouveaux derives de coumarines, leurs procedes de preparation et leur application comme medicaments en tant qu'inhibiteurs de proteases
|
JPH1149676A
(ja)
|
1997-07-31 |
1999-02-23 |
Geron Corp |
ピリジン系テロメラーゼ阻害剤
|
JPH11209366A
(ja)
|
1998-01-23 |
1999-08-03 |
Nissan Chem Ind Ltd |
クロマン誘導体及び心不全治療薬
|
DE69919707T2
(de)
|
1998-06-19 |
2005-09-01 |
Chiron Corp., Emeryville |
Glycogen synthase kinase 3 inhibitoren
|
AR019190A1
(es)
|
1998-07-08 |
2001-12-26 |
Sod Conseils Rech Applic |
Derivados de 2-aminopiridinas, productos intermedios para su preparacion, medicamentos y composiciones farmaceuticas que los contienen y su uso para preparar medicamentos
|
CA2367340A1
(fr)
|
1999-03-16 |
2000-09-21 |
Cytovia, Inc. |
Inhibiteurs de caspases 2-aminobenzamidiques substitues et leur utilisation
|
GB9922171D0
(en)
|
1999-09-21 |
1999-11-17 |
Zeneca Ltd |
Chemical compounds
|
BRPI0113286B8
(pt)
|
2000-08-14 |
2021-05-25 |
Johnson & Johnson |
pirazóis substituídos e composição farmacêutica compreendendo os mesmos.
|
DE60136546D1
(de)
|
2000-09-06 |
2008-12-24 |
Ortho Mcneil Pharm Inc |
Methode zum bekämpfen der allergien durch verwendung von substituierten pyrazolen
|
AU2001292276A1
(en)
|
2000-09-27 |
2002-04-08 |
Toray Industries, Inc. |
Nitrogen-containing compounds and ccr3 inhibitors containing the same as the active ingredient
|
HN2001000224A
(es)
|
2000-10-19 |
2002-06-13 |
Pfizer |
Compuestos de imidazol condensado con arilo o heteroarilo como agentes anti - inflamatorios y analgesicos.
|
US6710058B2
(en)
|
2000-11-06 |
2004-03-23 |
Bristol-Myers Squibb Pharma Company |
Monocyclic or bicyclic carbocycles and heterocycles as factor Xa inhibitors
|
AU3950802A
(en)
|
2000-12-07 |
2002-06-18 |
Cv Therapeutics Inc |
Abca-1 elevating compounds
|
WO2002053160A1
(fr)
|
2000-12-29 |
2002-07-11 |
Alteon, Inc. |
Methode de traitement du glaucome ivb
|
RU2319701C2
(ru)
|
2001-02-21 |
2008-03-20 |
Астразенека Аб |
ГЕТЕРОПОЛИЦИКЛИЧЕСКОЕ СОЕДИНЕНИЕ, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, ОБЛАДАЮЩАЯ АНТАГОНИСТИЧЕСКОЙ АКТИВНОСТЬЮ В ОТНОШЕНИИ МЕТАБОТРОПНЫХ ГЛЮТАМАТНЫХ РЕЦЕПТОРОВ mGluR ГРУППЫ I
|
EP1408986B1
(fr)
|
2001-05-08 |
2008-09-24 |
Yale University |
Composes proteomimetiques et procedes correspondants
|
WO2003042190A1
(fr)
|
2001-11-12 |
2003-05-22 |
Pfizer Products Inc. |
Derives de n-adamantylalkyle benzamide en tant qu'antagonistes du recepteur p2x7
|
US20030187026A1
(en)
|
2001-12-13 |
2003-10-02 |
Qun Li |
Kinase inhibitors
|
TW200301698A
(en)
|
2001-12-21 |
2003-07-16 |
Bristol Myers Squibb Co |
Acridone inhibitors of IMPDH enzyme
|
JP2003192673A
(ja)
|
2001-12-27 |
2003-07-09 |
Bayer Ag |
ピペラジンカルボキシアミド誘導体
|
WO2003062224A1
(fr)
|
2002-01-17 |
2003-07-31 |
Eli Lilly And Company |
Composes azacycliques en tant que modulateurs de recepteurs d'acetylcholine
|
JP4167848B2
(ja)
|
2002-04-10 |
2008-10-22 |
広栄化学工業株式会社 |
ビアリール化合物の製造法
|
CN1181065C
(zh)
|
2002-05-08 |
2004-12-22 |
上海医药工业研究院 |
芳烷甲酰烷基哌嗪衍生物及其作为脑神经保护剂的应用
|
US20040082627A1
(en)
|
2002-06-21 |
2004-04-29 |
Darrow James W. |
Certain aromatic monocycles as kinase modulators
|
US7015227B2
(en)
|
2002-06-21 |
2006-03-21 |
Cgi Pharmaceuticals, Inc. |
Certain amino-substituted monocycles as kinase modulators
|
JP4741948B2
(ja)
|
2002-08-14 |
2011-08-10 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
プロテインキナーゼインヒビターおよびそれらの使用
|
US7632858B2
(en)
|
2002-11-15 |
2009-12-15 |
Bristol-Myers Squibb Company |
Open chain prolyl urea-related modulators of androgen receptor function
|
CA2515544A1
(fr)
|
2003-02-11 |
2004-08-26 |
Kemia Inc. |
Composes destines au traitement d'une infection virale
|
CL2004000234A1
(es)
|
2003-02-12 |
2005-04-15 |
Biogen Idec Inc |
Compuestos derivados 3-(piridin-2-il)-4-heteroaril-pirazol sustituidos, antagonistas de aik5 y/o aik4; composicion farmaceutica y uso del compuesto en el tratamiento de desordenes fibroticos como esclerodermia, lupus nefritico, cicatrizacion de herid
|
EP2080757A1
(fr)
|
2003-07-24 |
2009-07-22 |
Euro-Celtique S.A. |
Composés de hétéroaryl-tétrahydropipéridyle utiles pour traiter ou prévenir la douleur
|
TWI287567B
(en)
|
2003-07-30 |
2007-10-01 |
Chi Mei Optoelectronics Corp |
Light-emitting element and iridium complex
|
EP1651638A1
(fr)
|
2003-08-08 |
2006-05-03 |
Janssen Pharmaceutica N.V. |
Urees pyridyle piperazinyle
|
WO2005016862A1
(fr)
|
2003-08-14 |
2005-02-24 |
Asahi Kasei Pharma Corporation |
Derive d'acide arylalcanoique substitue et son utilisation
|
US7504401B2
(en)
|
2003-08-29 |
2009-03-17 |
Locus Pharmaceuticals, Inc. |
Anti-cancer agents and uses thereof
|
EP1663953A1
(fr)
|
2003-09-24 |
2006-06-07 |
Methylgene, Inc. |
Inhibiteurs d'histone deacetylase
|
JP2007524682A
(ja)
|
2004-02-12 |
2007-08-30 |
メルク エンド カムパニー インコーポレーテッド |
代謝調節型グルタミン酸受容体−5の調節物質としてのビピリジルアミド
|
BRPI0508230A
(pt)
|
2004-03-30 |
2007-07-17 |
Chiron Corp |
derivados de tiofeno substituìdo como agentes anti-cáncer
|
ATE454372T1
(de)
|
2004-04-01 |
2010-01-15 |
Lilly Co Eli |
Am histamin-h3-rezeptor wirksame mittel, herstellung und therapeutische anwendungen
|
US7459562B2
(en)
|
2004-04-23 |
2008-12-02 |
Bristol-Myers Squibb Company |
Monocyclic heterocycles as kinase inhibitors
|
FR2869904B1
(fr)
|
2004-05-07 |
2006-07-28 |
Fournier S A Sa Lab |
Modulateurs des recepteurs lxr
|
ATE432926T1
(de)
|
2004-07-26 |
2009-06-15 |
Lilly Co Eli |
Oxazolderivate als histamin-h3-rezeptor- wirkstoffe, deren herstellung und therapeutische verwendung
|
JP2008516989A
(ja)
|
2004-10-19 |
2008-05-22 |
コンパス ファーマシューティカルズ リミティド ライアビリティ カンパニー |
組成物及び抗腫瘍剤としてのその使用
|
CA2585490A1
(fr)
|
2004-11-12 |
2006-05-18 |
Galapagos Nv |
Composes heteroaromatiques de l'azote qui se lient au site actif d'enzymes de type proteines kinases
|
CA2588389A1
(fr)
|
2004-11-23 |
2006-06-22 |
Ptc Therapeutics, Inc. |
Phenols substitues en tant qu'agents actifs inhibant la production de vegf
|
CA2589773A1
(fr)
|
2004-12-22 |
2006-06-29 |
Astrazeneca Ab |
Derives de pyridinecarboxamide employes en tant qu'agents anticancereux
|
WO2006067445A2
(fr)
|
2004-12-22 |
2006-06-29 |
Astrazeneca Ab |
Composes chimiques
|
EP2354126B1
(fr)
|
2005-01-14 |
2013-09-25 |
ChemoCentryx, Inc. |
Sulfonamides d'hétéroarylamide et CCR2
|
US7622583B2
(en)
|
2005-01-14 |
2009-11-24 |
Chemocentryx, Inc. |
Heteroaryl sulfonamides and CCR2
|
EP1683796A1
(fr)
|
2005-01-24 |
2006-07-26 |
Schering Aktiengesellschaft |
Pyrazolopyridines, leur préparation et leur utilisation médicale
|
JP2008528580A
(ja)
|
2005-01-27 |
2008-07-31 |
アストラゼネカ・アクチエボラーグ |
P2x7受容体の阻害剤である新規二環式芳香族化合物
|
US7888374B2
(en)
|
2005-01-28 |
2011-02-15 |
Abbott Laboratories |
Inhibitors of c-jun N-terminal kinases
|
US20060178388A1
(en)
|
2005-02-04 |
2006-08-10 |
Wrobleski Stephen T |
Phenyl-substituted pyrimidine compounds useful as kinase inhibitors
|
US20070135437A1
(en)
|
2005-03-04 |
2007-06-14 |
Alsgen, Inc. |
Modulation of neurodegenerative diseases
|
EP1879881A2
(fr)
|
2005-04-14 |
2008-01-23 |
Bristol-Myers Squibb Company |
Inhibiteurs de la 11-beta hydroxysteroide deshydrogenase de type i
|
US7682404B2
(en)
|
2005-05-13 |
2010-03-23 |
Ciba Specialty Chemicals Corporation |
Coloring keratin fibers with metal complexes
|
WO2006128172A2
(fr)
|
2005-05-26 |
2006-11-30 |
Synta Pharmaceuticals Corp. |
Procede pour traiter des troubles auto-immuns regules par des lymphocytes b
|
WO2006128129A2
(fr)
|
2005-05-26 |
2006-11-30 |
Synta Pharmaceuticals Corp. |
Traitement anticancereux
|
AU2006252768A1
(en)
|
2005-06-02 |
2006-12-07 |
Bayer Cropscience Ag |
Phenylalkyl substituted heteroaryl devivatives
|
AU2006258101A1
(en)
|
2005-06-09 |
2006-12-21 |
Merck Sharp & Dohme Corp. |
Inhibitors of checkpoint kinases
|
AR053901A1
(es)
|
2005-06-20 |
2007-05-23 |
Astrazeneca Ab |
Formas fisicas de oxabispidinas n,n'- disustituidas
|
ATE455103T1
(de)
|
2005-06-24 |
2010-01-15 |
Bristol Myers Squibb Co |
Als antikoagulationsmittel geeignete phenylglycinamid- und pyridylglycinamidderivate
|
PE20070099A1
(es)
|
2005-06-30 |
2007-02-06 |
Janssen Pharmaceutica Nv |
N-heteroarilpiperazinil ureas como moduladores de la amida hidrolasa del acido graso
|
WO2007008541A2
(fr)
|
2005-07-08 |
2007-01-18 |
Kalypsys, Inc. |
Modificateurs d'absorption de cholesterol cellulaire
|
FR2892412B1
(fr)
|
2005-10-26 |
2008-05-16 |
Galderma Res & Dev |
Composes biaromatiques modulateurs des ppars
|
TW200804307A
(en)
|
2005-10-27 |
2008-01-16 |
Synta Pharmaceuticals Corp |
Process for preparing mesylate salts of IL-12 inhibitory compounds
|
WO2007055941A2
(fr)
|
2005-11-03 |
2007-05-18 |
Merck & Co., Inc. |
Inhibiteurs de l'histone desacetylase a motifs d'aryle-pyrazolyle
|
HUE032640T2
(en)
|
2005-11-08 |
2017-10-30 |
Vertex Pharma |
Heterocyclic modulator of ATP-binding cassette transcripts
|
WO2007055374A1
(fr)
|
2005-11-14 |
2007-05-18 |
Mitsubishi Tanabe Pharma Corporation |
Agent therapeutique pour l'osteoporose
|
AR057579A1
(es)
|
2005-11-23 |
2007-12-05 |
Merck & Co Inc |
Compuestos espirociclicos como inhibidores de histona de acetilasa (hdac)
|
AU2006320580B2
(en)
|
2005-11-30 |
2011-06-23 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of c-Met and uses thereof
|
CA2633425A1
(fr)
|
2005-12-23 |
2007-06-28 |
F. Hoffmann-La Roche Ag |
Derives d'aryl-isoxazolo-4-yl-oxadiazole
|
JP2009523726A
(ja)
|
2006-01-12 |
2009-06-25 |
メルク エンド カムパニー インコーポレーテッド |
ヒドロキシアルキルアリールアミド誘導体
|
WO2007087129A2
(fr)
|
2006-01-12 |
2007-08-02 |
Merck & Co., Inc. |
Derives d’arylamide fluore
|
TW200813015A
(en)
|
2006-03-15 |
2008-03-16 |
Mitsubishi Pharma Corp |
2-(cyclic amino)-pyrimidone derivatives
|
JP2007283748A
(ja)
|
2006-03-23 |
2007-11-01 |
Fujifilm Corp |
光記録媒体および可視情報記録方法
|
DK2368550T3
(da)
|
2006-03-27 |
2013-09-30 |
Univ California |
Androgenreceptormodulator til behandlingen af prostatakræft og androgenreceptor-associerede sygdomme
|
ES2452820T3
(es)
|
2006-04-07 |
2014-04-02 |
Methylgene, Inc. |
Derivados de benzamida como inhibidores de histona desacetilasa
|
WO2007125984A1
(fr)
|
2006-04-28 |
2007-11-08 |
Nihon Nohyaku Co., Ltd. |
Derive isoxazoline, agent insecticide et utilisation de l'agent insecticide
|
US20090118336A1
(en)
|
2006-05-03 |
2009-05-07 |
Laurent David |
Pyrazole derivatives and their use as pi3k inhibitors
|
JP2009535386A
(ja)
|
2006-05-03 |
2009-10-01 |
アストラゼネカ アクチボラグ |
チアゾール誘導体および抗腫瘍剤としてのその使用
|
US20080064871A1
(en)
|
2006-05-26 |
2008-03-13 |
Japan Tobacco Inc. |
Production Method of Nitrogen-Containing Fused Ring Compounds
|
DE602007006010D1
(de)
|
2006-05-31 |
2010-06-02 |
Galapagos Nv |
Triazolopyrazinverbindungen zur behandlung von degenerations- und entzündungskrankheiten
|
US20100022547A1
(en)
|
2006-06-02 |
2010-01-28 |
Brandeis University |
Compounds and Methods for Treating Mammalian Gastrointestinal Parasitic Infections
|
US20080280891A1
(en)
|
2006-06-27 |
2008-11-13 |
Locus Pharmaceuticals, Inc. |
Anti-cancer agents and uses thereof
|
WO2008005457A2
(fr)
|
2006-06-30 |
2008-01-10 |
Sunesis Pharmaceuticals |
Inhibiteurs de pyridinonyle pdk1
|
US8519135B2
(en)
|
2006-07-14 |
2013-08-27 |
Chemocentryx, Inc. |
Heteroaryl sulfonamides and CCR2/CCR9
|
US7981874B2
(en)
|
2006-07-20 |
2011-07-19 |
Merck Sharp & Dohme Corp. |
Phosphorus derivatives as histone deacetylase inhibitors
|
GB0614579D0
(en)
|
2006-07-21 |
2006-08-30 |
Black James Foundation |
Pyrimidine derivatives
|
EP2057124A2
(fr)
|
2006-07-21 |
2009-05-13 |
Irm, Llc |
Composés et compositions utilisés en tant qu'inhibiteurs de l'itpkb
|
FR2903985B1
(fr)
|
2006-07-24 |
2008-09-05 |
Sanofi Aventis Sa |
Derives de n-(amino-heteroaryl)-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique
|
WO2008013963A2
(fr)
|
2006-07-28 |
2008-01-31 |
University Of Connecticut |
Inhibiteurs d'hydrolase des amides d'acides gras
|
WO2008016643A2
(fr)
|
2006-08-01 |
2008-02-07 |
Cytokinetics, Incorporated |
Entités chimiques, compositions et méthodes
|
WO2008024978A2
(fr)
|
2006-08-24 |
2008-02-28 |
Serenex, Inc. |
Dérivés de benzène, de pyridine et de pyridazine
|
US20080076813A1
(en)
|
2006-08-24 |
2008-03-27 |
Huang Kenneth H |
Benzene, Pyridine, and Pyridazine Derivatives
|
EP2066676A1
(fr)
|
2006-09-18 |
2009-06-10 |
Vertex Pharmaceuticals, Inc. |
INHIBITEURS HÉTÉROCYCLIQUES DE c-MET ET LEURS UTILISATIONS
|
DK2076508T3
(da)
|
2006-10-18 |
2011-02-21 |
Pfizer Prod Inc |
Biaryl-ether-urinstof-forbindelser
|
DE102006050515A1
(de)
|
2006-10-26 |
2008-04-30 |
Bayer Healthcare Ag |
Substituierte Dipyridiyl-dihydropyrazolone und ihre Verwendung
|
US7858645B2
(en)
|
2006-11-01 |
2010-12-28 |
Hoffmann-La Roche Inc. |
Indazole derivatives
|
WO2008053913A1
(fr)
|
2006-11-02 |
2008-05-08 |
Shionogi & Co., Ltd. |
Dérivé de sulfonylurée capable d'inhiber sélectivement mmp-13
|
JP2009023986A
(ja)
|
2006-11-08 |
2009-02-05 |
Pharma Ip |
抗癌剤としてのビアリール誘導体
|
US20080145816A1
(en)
|
2006-12-15 |
2008-06-19 |
Hershey Adrienne A |
Yankauer suction device
|
DK2125822T3
(en)
|
2006-12-21 |
2015-01-12 |
Nerviano Medical Sciences Srl |
SUBSTITUTED PYRAZOLOQUINAZOLINDERIVATER, process for their preparation and their use as kinase inhibitors
|
FR2910473B1
(fr)
|
2006-12-26 |
2009-02-13 |
Sanofi Aventis Sa |
Derives de n-(amino-heteroaryl)-1h-pyrrolopyridine-2- carboxamides, leur preparation et leur application en therapeutique.
|
AR064660A1
(es)
|
2006-12-26 |
2009-04-15 |
Mitsubishi Tanabe Pharma Corp |
Derivados de pirimidinona 6-heterociclica 2-sustituida, medicamentos que los contienen y usos para prevenir y/o tratar enfermedades neurodegenerativas entre otras
|
JP2008179068A
(ja)
|
2007-01-25 |
2008-08-07 |
Fujifilm Corp |
光記録媒体および可視情報記録方法
|
JP2008179067A
(ja)
|
2007-01-25 |
2008-08-07 |
Fujifilm Corp |
光記録媒体および可視情報記録方法
|
ES2702362T3
(es)
|
2007-01-31 |
2019-02-28 |
Ym Biosciences Australia Pty |
Compuestos a base de tiopirimidina y usos de los mismos
|
MX2009009936A
(es)
|
2007-03-20 |
2010-02-11 |
Curis Inc |
Amino piridina fusionada como inhibidores de hsp90.
|
WO2008115262A2
(fr)
|
2007-03-20 |
2008-09-25 |
Curis, Inc. |
Inhibiteurs de hsp90 contenant une fraction de liaison de zinc
|
US8461343B2
(en)
|
2007-03-27 |
2013-06-11 |
Sloan-Kettering Institute For Cancer Research |
Synthesis of thiohydantoins
|
FR2915198B1
(fr)
|
2007-04-18 |
2009-12-18 |
Sanofi Aventis |
Derives de triazolopyridine-carboxamides et triazolopyridine -carboxamides, leur preparation et leur application en therapeutique.
|
US20100120839A1
(en)
|
2007-04-20 |
2010-05-13 |
Biolipox Ab |
Pyrazoles useful in the treatment of inflammation
|
WO2008139152A1
(fr)
|
2007-05-11 |
2008-11-20 |
Sentinel Oncology Limited |
Composés pharmaceutiques contenant un n-oxyde
|
MX2009013169A
(es)
|
2007-06-03 |
2010-04-30 |
Univ Vanderbilt |
Moduladores alostericos positivos del mglur5 benzamida y metodos de elaboracion y uso de los mismos.
|
NZ581610A
(en)
|
2007-06-05 |
2012-02-24 |
Sanofi Aventis |
Substituted benzoylamino-indan-2-carboxylic acids and related compounds
|
US7928111B2
(en)
|
2007-06-08 |
2011-04-19 |
Senomyx, Inc. |
Compounds including substituted thienopyrimidinone derivatives as ligands for modulating chemosensory receptors
|
US8633186B2
(en)
|
2007-06-08 |
2014-01-21 |
Senomyx Inc. |
Modulation of chemosensory receptors and ligands associated therewith
|
CN101808518A
(zh)
|
2007-06-27 |
2010-08-18 |
默沙东公司 |
作为组蛋白脱乙酰酶抑制剂的吡啶基和嘧啶基衍生物
|
WO2009022171A1
(fr)
|
2007-08-13 |
2009-02-19 |
Astrazeneca Ab |
Composés chimiques 1 - 821
|
ES2535166T3
(es)
|
2007-09-04 |
2015-05-06 |
The Scripps Research Institute |
Pirimidinil-aminas sustituidas como inhibidores de proteína-quinasas
|
US8354383B2
(en)
|
2007-09-17 |
2013-01-15 |
Enanta Pharmaceuticals, Inc. |
6,11-bridged biaryl macrolides
|
WO2009037001A2
(fr)
|
2007-09-19 |
2009-03-26 |
4Sc Ag |
Nouvelles pyridines tétrahydrocondensées
|
JP5469604B2
(ja)
|
2007-09-19 |
2014-04-16 |
4エスツェー アクチェンゲゼルシャフト |
新規テトラヒドロ融合ピリジン
|
CA2702946A1
(fr)
|
2007-10-16 |
2009-04-23 |
Northeastern University |
Inhibiteurs de la monoacylglycerol lipase de modulation de l'activite cannabinoide
|
US20090156825A1
(en)
|
2007-11-26 |
2009-06-18 |
Heidebrecht Jr Richard W |
Fluorescent compounds that bind to histone deacetylase
|
WO2009078992A1
(fr)
|
2007-12-17 |
2009-06-25 |
Amgen Inc. |
Composés tricycliques linéaires utilisés comme inhibiteurs de la kinase p38
|
FR2926553B1
(fr)
|
2008-01-23 |
2010-02-19 |
Sanofi Aventis |
Derives d'indole-2-carboxamides et d'azaindole-2- carboxamides substitues par un groupe silanyle, leur preparation et leur application en therapeutique
|
US20110098267A1
(en)
|
2008-02-07 |
2011-04-28 |
Synta Pharmaceuticals Corporation |
Topical formulations for the treatment of psoriasis
|
JP2009209090A
(ja)
|
2008-03-04 |
2009-09-17 |
Mitsui Chemicals Inc |
殺虫剤及び該殺虫剤に含まれる化合物、並びに該化合物の使用方法
|
CL2009000600A1
(es)
|
2008-03-20 |
2010-05-07 |
Bayer Cropscience Ag |
Uso de compuestos de diaminopirimidina como agentes fitosanitarios; compuestos de diaminopirimidina; su procedimiento de preparacion; agente que los contiene; procedimiento para la preparacion de dicho agente; y procedimiento para combatir plagas de animales y/u hongos dañinos patogenos de plantas.
|
WO2009143018A2
(fr)
|
2008-05-19 |
2009-11-26 |
Plexxikon, Inc. |
Composés et procédés de modulation des kinases, et indications associées
|
PE20091846A1
(es)
|
2008-05-19 |
2009-12-16 |
Plexxikon Inc |
DERIVADOS DE PIRROLO[2,3-d]-PIRIMIDINA COMO MODULADORES DE CINASAS
|
WO2009152083A1
(fr)
|
2008-06-10 |
2009-12-17 |
Plexxikon, Inc. |
Dérivés 5h-pyrrolo-[2,3-b]-pyrazine destinés à la modulation de kinases, et des indications pour ceux-ci
|
WO2009152087A1
(fr)
|
2008-06-10 |
2009-12-17 |
Plexxikon, Inc. |
Composés hétéroaryles bicycliques et procédés destinés à la modulation de kinases, et des indications pour celle-ci
|
MX2010013876A
(es)
|
2008-06-20 |
2011-03-04 |
Metabolex Inc |
Agonistas de arilo grpr119 y sus usos .
|
MX2010014572A
(es)
|
2008-06-27 |
2011-03-24 |
Novartis Ag |
Compuestos organicos.
|
JP5309216B2
(ja)
|
2008-07-11 |
2013-10-09 |
アイアールエム・リミテッド・ライアビリティ・カンパニー |
Gpr119活性のモジュレーターとしての4−フェノキシメチルピペリジン類
|
TW201028381A
(en)
|
2008-07-14 |
2010-08-01 |
Shionogi & Co |
Pyridine derivative having ttk inhibition activity
|
KR20110028661A
(ko)
|
2008-07-15 |
2011-03-21 |
노파르티스 아게 |
Dgat1 억제제로서의 헤테로아릴 유도체
|
US8722686B2
(en)
|
2008-09-19 |
2014-05-13 |
Pfizer Inc. |
Hydroxamic acid derivatives useful as antibacterial agents
|
BRPI0920608A2
(pt)
|
2008-09-29 |
2019-09-24 |
Boehringer Ingelheim Int |
compostos quimicos
|
WO2010046780A2
(fr)
|
2008-10-22 |
2010-04-29 |
Institut Pasteur Korea |
Composés antiviraux
|
WO2010068863A2
(fr)
|
2008-12-12 |
2010-06-17 |
Cystic Fibrosis Foundation Therapeutics, Inc. |
Composés de pyrimidine et leurs procédés de fabrication et d'utilisation
|
RU2505540C2
(ru)
|
2008-12-23 |
2014-01-27 |
Эббви Инк. |
Антивирусные соединения
|
WO2010088574A1
(fr)
|
2009-01-30 |
2010-08-05 |
Sirtris Pharmaceuticals, Inc. |
Azabenzimidazoles et analogues apparentés en tant que modulateurs de la sirtuine
|
WO2010111527A1
(fr)
|
2009-03-26 |
2010-09-30 |
Plexxikon, Inc. |
Pyrazolo [ 3, 4 -b] pyridines en tant qu'inhibiteurs de la kinase et leur utilisation médicale
|
EP2417125B1
(fr)
|
2009-03-27 |
2015-09-09 |
Nerviano Medical Sciences S.r.l. |
Dérivés de n-aryl-2-(2-arylaminopyrimidin-4-yl)pyrrol-4-carboxamide comme inhibiteurs de mps1 kinase
|
EP2414366A1
(fr)
|
2009-04-01 |
2012-02-08 |
Novartis AG |
Dérivés spiro pour la modulation de la stéaroyl-coa désaturase
|
AR076753A1
(es)
|
2009-05-07 |
2011-07-06 |
Gruenenthal Chemie |
Derivados de carboxamida y urea aromaticas sustituidas como ligandos del receptor de vanilloides.
|
JP2011006408A
(ja)
|
2009-05-29 |
2011-01-13 |
Sumitomo Chemical Co Ltd |
神経栄養因子の活性が関与する疾患の治療または予防剤
|
KR20120031170A
(ko)
|
2009-06-08 |
2012-03-30 |
길리애드 사이언시즈, 인코포레이티드 |
알카노일아미노 벤즈아미드 아닐린 hdac 저해제 화합물
|
WO2010151747A1
(fr)
|
2009-06-26 |
2010-12-29 |
Cystic Fibrosis Foundation Therapeutics, Inc. |
Composés de pyramine ainsi que leurs procédés de fabrication et d'utilisation
|
WO2011008931A2
(fr)
|
2009-07-15 |
2011-01-20 |
Cystic Fibrosis Foundation Therapeutics, Inc. |
Composés arylpyrimidines et thérapie de combinaison comprenant ceux-ci pour traiter une mucoviscidose et des troubles apparentés
|
US8415381B2
(en)
|
2009-07-30 |
2013-04-09 |
Novartis Ag |
Heteroaryl compounds and their uses
|
WO2011072275A2
(fr)
|
2009-12-11 |
2011-06-16 |
Nono, Inc. |
Agents et méthodes de traitement de maladies ischémiques et d'autres maladies
|
CA2784757A1
(fr)
|
2009-12-16 |
2011-07-07 |
Novo Nordisk A/S |
Derives a double acylation de glp-1
|
WO2011082400A2
(fr)
|
2010-01-04 |
2011-07-07 |
President And Fellows Of Harvard College |
Modulateurs du récepteur immunosuppresseur pd-1 et procédés d'utilisation de ceux-ci
|
US20130137728A1
(en)
|
2010-03-24 |
2013-05-30 |
MUSC Foundation for Research and Development |
Compositions and Methods for the Treatment of Degenerative Diseases
|
BR122017022928B1
(pt)
|
2010-04-06 |
2018-03-06 |
Nippon Soda Co., Ltd. |
Método para produção de composto heterocíclico que contém nitrogênio
|
US9133123B2
(en)
|
2010-04-23 |
2015-09-15 |
Cytokinetics, Inc. |
Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use
|
US8217044B2
(en)
|
2010-04-28 |
2012-07-10 |
Hoffmann-La Roche Inc. |
Spiroindolinone pyrrolidines
|
CN107021951B
(zh)
|
2010-06-30 |
2020-10-20 |
赛克里翁治疗有限公司 |
sGC刺激物
|
WO2012004217A1
(fr)
|
2010-07-06 |
2012-01-12 |
Novartis Ag |
Composés éthers cycliques utiles comme inhibiteurs de kinase
|
US8883839B2
(en)
|
2010-08-13 |
2014-11-11 |
Abbott Laboratories |
Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy
|
US9051280B2
(en)
|
2010-08-13 |
2015-06-09 |
AbbVie Deutschland GmbH & Co. KG |
Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy
|
US8846743B2
(en)
|
2010-08-13 |
2014-09-30 |
Abbott Laboratories |
Aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy
|
WO2012024604A2
(fr)
|
2010-08-20 |
2012-02-23 |
President And Fellows Of Harvard College |
Complexes de fluorure de palladium de valence élevée et leurs utilisations
|
JP2012107001A
(ja)
|
2010-10-22 |
2012-06-07 |
Shionogi & Co Ltd |
インドールアミド化合物を含有する医薬
|
WO2012061337A1
(fr)
|
2010-11-02 |
2012-05-10 |
Exelixis, Inc. |
Modulateurs de fgfr2
|
AU2011326241B2
(en)
|
2010-11-09 |
2016-11-17 |
Ironwood Pharmaceuticals, Inc. |
sGC stimulators
|
WO2012074050A1
(fr)
|
2010-12-01 |
2012-06-07 |
富士フイルム株式会社 |
Film polymère, film de différence de phase, plaque de polarisation, dispositif d'affichage à cristaux liquides et composé
|
WO2012085789A1
(fr)
|
2010-12-21 |
2012-06-28 |
Koninklijke Philips Electronics N.V. |
Agents pour l'élimination de biomolécules hors de la circulation
|
ES2570784T3
(es)
|
2010-12-22 |
2016-05-20 |
Purdue Pharma Lp |
Piridinas sustituidas como bloqueadores de los canales de sodio
|
US20120184572A1
(en)
|
2011-01-13 |
2012-07-19 |
Metabolex, Inc. |
Aryl gpr119 agonists and uses thereof
|
CN103339110A
(zh)
|
2011-01-28 |
2013-10-02 |
诺瓦提斯公司 |
作为cdk9抑制剂的取代的杂-联芳基化合物及其用途
|
US8957066B2
(en)
*
|
2011-02-28 |
2015-02-17 |
Biomarin Pharmaceutical Inc. |
Histone deacetylase inhibitors
|
US20140057953A1
(en)
|
2011-03-03 |
2014-02-27 |
Rolf Hartmann |
Biaryl derivatives as selective 17beta-hydroxysteroid dehydrogenase type 2 inhibitors
|
GB201104267D0
(en)
|
2011-03-14 |
2011-04-27 |
Cancer Rec Tech Ltd |
Pyrrolopyridineamino derivatives
|
CA2829466A1
(fr)
|
2011-03-18 |
2012-09-27 |
Lupin Limited |
Derives de benzo [b] [1,4] oxazine en tant que modulateurs du recepteur sensible au calcium
|
WO2012147890A1
(fr)
|
2011-04-27 |
2012-11-01 |
持田製薬株式会社 |
Nouveau dérivé d'azole
|
JP6240063B2
(ja)
|
2011-04-28 |
2017-11-29 |
ザ ブロード インスティテュート, インコーポレイテッド |
ヒストンデアセチラーゼ阻害剤
|
WO2012154880A1
(fr)
|
2011-05-09 |
2012-11-15 |
Proteostasis Therapeutics, Inc. |
Régulateurs de protéostasie pour le traitement de la mucoviscidose et autres maladies de mauvais repliement des protéines
|
US9309200B2
(en)
|
2011-05-12 |
2016-04-12 |
AbbVie Deutschland GmbH & Co. KG |
Benzazepine derivatives, pharmaceutical compositions containing them, and their use in therapy
|
ES2920373T3
(es)
|
2011-05-16 |
2022-08-03 |
Tagworks Pharmaceuticals B V |
Activación de fármaco bioortogonal
|
DK2713722T3
(en)
|
2011-05-31 |
2017-07-03 |
Celgene Int Ii Sarl |
Newly known GLP-1 receptor stabilizers and modulators
|
JP2013020223A
(ja)
|
2011-06-17 |
2013-01-31 |
Fujifilm Corp |
高分子フィルム、セルロースエステルフィルム、偏光板、及び液晶表示装置
|
MX2014000964A
(es)
|
2011-07-26 |
2014-03-27 |
Gruenenthal Gmbh |
Derivados aza heterociclicos sustituidos.
|
US20130029962A1
(en)
|
2011-07-26 |
2013-01-31 |
Gruenenthal Gmbh |
Substituted Heteroaromatic Pyrazole-Containing Carboxamide and Urea Compounds as Vanilloid Receptor Ligands
|
WO2013017480A1
(fr)
|
2011-07-29 |
2013-02-07 |
Cellzome Limited |
Dérivés de pyrazolo[4,3-c]pyridine en tant qu'inhibiteurs de jak
|
BR112014003112A2
(pt)
|
2011-08-12 |
2017-02-21 |
Basf Se |
composto da fórmula geral (i), métodos para preparar um composto da fórmula (i), composição agrícola ou veterinária, método para combater ou controlar pragas invertebradas, método para proteger o cultivo de plantas, método para a proteção de sementes, semente, usos de um composto e método para tratar um animal
|
EP2751086A4
(fr)
|
2011-08-30 |
2015-09-16 |
Chdi Foundation Inc |
Inhibiteurs de kynurénine-3-monooxygénase, compositions pharmaceutiques et procédés d'utilisation de ces compositions
|
WO2013038390A1
(fr)
|
2011-09-16 |
2013-03-21 |
Novartis Ag |
Hétérocyclyle carboxamides n-substitués
|
US9226505B2
(en)
|
2011-09-23 |
2016-01-05 |
Bayer Intellectual Property Gmbh |
4-substituted 1-phenylpyrazole-3-carboxylic acid derivatives as agents against abiotic plant stress
|
CN103987697B
(zh)
|
2011-10-14 |
2017-04-26 |
百时美施贵宝公司 |
作为因子xia抑制剂的取代的四氢异喹啉化合物
|
WO2013059648A1
(fr)
|
2011-10-21 |
2013-04-25 |
Neurotherapeutics Pharma, Inc. |
Dérivés aminés d'hétéroaryle et d'aryle 2,3,5 trisubstitués, compositions et procédés d'utilisation associés
|
WO2013064884A1
(fr)
|
2011-10-31 |
2013-05-10 |
Purdue Pharma L.P. |
Amines quaternisées en tant que bloqueurs des canaux sodiques
|
US9365512B2
(en)
|
2012-02-13 |
2016-06-14 |
AbbVie Deutschland GmbH & Co. KG |
Isoindoline derivatives, pharmaceutical compositions containing them, and their use in therapy
|
US9321763B2
(en)
|
2012-04-04 |
2016-04-26 |
Rigel Pharmaceuticals, Inc. |
Protein kinase C inhibitors and uses thereof
|
KR101749611B1
(ko)
|
2012-04-12 |
2017-06-21 |
벌시테크 리미티드 |
유기발광다이오드용 백금(ⅱ) 착화합물
|
US20150105433A1
(en)
|
2012-04-27 |
2015-04-16 |
The Uab Research Foundation |
TREATING VIRAL INFECTIONS HAVING VIRAL RNAs TRANSLATED BY A NON-IRES MEDIATED MECHANISM
|
JP6217629B2
(ja)
|
2012-05-31 |
2017-10-25 |
住友化学株式会社 |
縮合複素環化合物
|
US9013997B2
(en)
|
2012-06-01 |
2015-04-21 |
Broadcom Corporation |
System for performing distributed data cut-through
|
BR112014031068A2
(pt)
|
2012-06-12 |
2017-06-27 |
Abbvie Inc |
derivados piridinona e piridazinona
|
CN106905297A
(zh)
|
2012-06-15 |
2017-06-30 |
加利福尼亚大学董事会 |
用于脑癌的新颖治疗剂
|
CN103508961B
(zh)
|
2012-06-26 |
2015-07-22 |
中美冠科生物技术(太仓)有限公司 |
抗肿瘤药物
|
WO2014005125A2
(fr)
|
2012-06-29 |
2014-01-03 |
Biotium, Inc. |
Composés fluorescents et utilisation de ceux-ci
|
JP6483610B2
(ja)
|
2012-07-18 |
2019-03-13 |
ユニバーシティ オブ ノートルダム デュ ラック |
5,5−ヘテロ芳香族抗感染症化合物
|
CN103570625A
(zh)
|
2012-07-19 |
2014-02-12 |
南京英派药业有限公司 |
N-(3-杂芳基芳基)-4-芳基芳基甲酰胺和类似物作为Hedgehog通路抑制剂及其应用
|
WO2014025808A1
(fr)
|
2012-08-06 |
2014-02-13 |
The General Hospital Corporation |
Analogues de curcumine
|
WO2014031928A2
(fr)
|
2012-08-24 |
2014-02-27 |
Philip Jones |
Modulateurs hétérocycliques de l'activité du facteur hif utilisés pour le traitement de maladies
|
WO2014047111A1
(fr)
|
2012-09-18 |
2014-03-27 |
Ironwood Pharmaceuticals, Inc. |
Stimulateurs de la sgc
|
SG11201502527UA
(en)
|
2012-10-05 |
2015-04-29 |
Rigel Pharmaceuticals Inc |
Gdf-8 inhibitors
|
US9775843B2
(en)
|
2012-10-11 |
2017-10-03 |
Grünenthal GmbH |
Treatment and/or prophylaxis of TSPO mediated diseases and/or disorders
|
JP2014101353A
(ja)
|
2012-10-26 |
2014-06-05 |
Shionogi & Co Ltd |
オキサジン誘導体を含有するアルツハイマー症治療用または予防用医薬組成物
|
US9145412B2
(en)
|
2012-11-02 |
2015-09-29 |
Acetylon Pharmaceuticals, Inc. |
Selective HDAC1 and HDAC2 inhibitors
|
WO2014074906A1
(fr)
|
2012-11-09 |
2014-05-15 |
Indiana University Research And Technology Corporation |
Nouvelles utilisations d'effecteurs d'assemblage du vhb
|
WO2014081300A1
(fr)
|
2012-11-22 |
2014-05-30 |
Tagworks Pharmaceuticals B.V. |
Liposomes activables par des protéines de canal
|
WO2014081299A1
(fr)
|
2012-11-22 |
2014-05-30 |
Tagworks Pharmaceuticals B.V. |
Liposome pouvant être actif
|
US20150297741A1
(en)
|
2012-11-22 |
2015-10-22 |
Tagworks Pharmaceuticals B.V. |
Bio-orthogonal drug activation
|
EP2922574B1
(fr)
|
2012-11-22 |
2023-05-17 |
Tagworks Pharmaceuticals B.V. |
Groupe clivable par voie chimique
|
CA2892677A1
(fr)
|
2012-12-04 |
2014-06-12 |
Rigel Pharmaceuticals, Inc. |
Inhibiteurs de la proteine kinase c et utilisations de ceux-ci
|
CN103864754B
(zh)
|
2012-12-10 |
2016-12-21 |
中国科学院上海药物研究所 |
五元唑类杂环化合物及其制备方法、药物组合物和用途
|
WO2014164704A2
(fr)
|
2013-03-11 |
2014-10-09 |
The Broad Institute, Inc. |
Composés et compositions utilisables en vue du traitement du cancer
|
WO2014151936A1
(fr)
|
2013-03-14 |
2014-09-25 |
The Trustees Of Columbia University In The City Of New York |
Octahydropyrrolopyrroles, leur préparation et leur utilisation
|
WO2014153208A1
(fr)
|
2013-03-14 |
2014-09-25 |
Epizyme, Inc. |
Inhibiteurs d'arginine méthyltransférase et leurs utilisations
|
EP2968339A4
(fr)
|
2013-03-15 |
2017-02-15 |
Celgene Avilomics Research, Inc. |
Inhibiteurs mk2 et utilisations associées
|
MX2015012803A
(es)
|
2013-03-15 |
2016-08-19 |
Epizyme Inc |
Inhibidores de la carm1 y usos de los mismos.
|
CN105308020B
(zh)
|
2013-03-20 |
2018-01-26 |
豪夫迈·罗氏有限公司 |
脲衍生物及其作为脂肪酸结合蛋白(fabp)抑制剂的用途
|
WO2014181287A1
(fr)
|
2013-05-09 |
2014-11-13 |
Piramal Enterprises Limited |
Composés hétérocyclyliques et leurs utilisations
|
CN104163791B
(zh)
|
2013-05-20 |
2017-05-03 |
湖南化工研究院 |
N‑吡啶(杂)芳酰胺类化合物及其制备方法与应用
|
CN104163792B
(zh)
|
2013-05-20 |
2017-04-12 |
湖南化工研究院 |
N‑吡啶酰胺类化合物及其制备方法与应用
|
CA2911326A1
(fr)
|
2013-05-24 |
2014-11-27 |
The California Institute For Biomedical Research |
Composes pour le traitement de la tuberculose resistante aux medicaments et persistante
|
JP6640716B2
(ja)
|
2013-05-30 |
2020-02-05 |
ワシントン・ユニバーシティWashington University |
細菌感染症を治療するための化合物及び方法
|
CN104232076B
(zh)
|
2013-06-10 |
2019-01-15 |
代表亚利桑那大学的亚利桑那校董会 |
具有改进的发射光谱的磷光四齿金属络合物
|
GB2515785A
(en)
|
2013-07-03 |
2015-01-07 |
Redx Pharma Ltd |
Compounds
|
GB2516303A
(en)
|
2013-07-18 |
2015-01-21 |
Redx Pharma Ltd |
Compounds
|
US9359330B2
(en)
|
2013-08-26 |
2016-06-07 |
Purdue Pharma L.P. |
Substituted piperidines as sodium channel blockers
|
WO2015031725A1
(fr)
|
2013-08-30 |
2015-03-05 |
President And Fellows Of Harvard College |
Imidation d'arènes catalysée par des métaux de transition
|
EA201690230A1
(ru)
|
2013-09-06 |
2016-07-29 |
Инсепшн 2, Инк. |
Соединения триазолона и их применения
|
US9663508B2
(en)
|
2013-10-01 |
2017-05-30 |
Amgen Inc. |
Biaryl acyl-sulfonamide compounds as sodium channel inhibitors
|
KR102307387B1
(ko)
|
2013-10-08 |
2021-09-30 |
큉-빈 루 |
표적화된 화학요법에 사용하기 위한 비백금기반 항암 화합물
|
PT3060550T
(pt)
|
2013-10-21 |
2019-08-27 |
Merck Patent Gmbh |
Compostos de heteroarilo como inibidores de btk e utilizações dos mesmos
|
CA2931097A1
(fr)
|
2013-11-19 |
2015-05-28 |
Vanderbilt University |
Composes imidazopyridine et triazolopyridine substitues utilises comme modulateurs allosteriques negatifs de mglur
|
CN103601718A
(zh)
|
2013-12-05 |
2014-02-26 |
江西天人生态股份有限公司 |
一类基于鱼泥丁受体的邻甲酰氨基苯甲酰胺衍生物及其制备方法和用途
|
WO2015110999A1
(fr)
|
2014-01-24 |
2015-07-30 |
Piramal Enterprises Limited |
Inhibiteurs de ezh2 et leurs utilisations
|
CN103804312B
(zh)
|
2014-02-17 |
2016-04-20 |
四川百利药业有限责任公司 |
一类氮杂环化合物及其制备方法和用途
|
WO2015142903A2
(fr)
|
2014-03-17 |
2015-09-24 |
Genentech, Inc. |
Procédé pour réguler la production de lactate à l'aide de dérivés de pipéridine-dione
|
US9533982B2
(en)
|
2014-03-20 |
2017-01-03 |
Vanderbilt University |
Substituted bicyclic heteroaryl carboxamide analogs as mGluR5 negative allosteric modulators
|
GB201405002D0
(en)
|
2014-03-20 |
2014-05-07 |
Isis Innovation |
Fluorination method
|
US11691997B2
(en)
|
2014-04-09 |
2023-07-04 |
Lumiphore, Inc. |
Macrocycles
|
EP3140298A1
(fr)
|
2014-05-07 |
2017-03-15 |
Pfizer Inc. |
Inhibiteurs de kinases apparentées à la tropomyosine
|
CN106535891A
(zh)
*
|
2014-06-02 |
2017-03-22 |
Chdi基金会股份有限公司 |
组蛋白脱乙酰酶抑制剂及其组合物和使用方法
|
US20170349540A1
(en)
|
2014-07-28 |
2017-12-07 |
The General Hospital Corporation |
Histone deacetylase inhibitors
|
EP3177622A1
(fr)
|
2014-08-04 |
2017-06-14 |
Fundacion para la Investigacion Medica Aplicada |
Nouveaux composés à utiliser pour améliorer la cognition
|
US9701685B2
(en)
|
2014-08-18 |
2017-07-11 |
Hudson Biopharma Inc. |
Spiropyrrolidines as MDM2 inhibitors
|
GB201416513D0
(en)
|
2014-09-18 |
2014-11-05 |
Astex Therapeutics Ltd And Cancer Res Technology Ltd |
Pharmaceutical compounds
|
US9550778B2
(en)
|
2014-10-03 |
2017-01-24 |
Vanderbilt University |
Substituted 6-aryl-imidazopyridine and 6-aryl-triazolopyridine carboxamide analogs as negative allosteric modulators of mGluR5
|
WO2016057779A2
(fr)
|
2014-10-08 |
2016-04-14 |
Acetylon Pharmaceuticals, Inc. |
Induction de gata2 par des inhibiteurs de hdac1 et hdac2
|
WO2016058544A1
(fr)
|
2014-10-16 |
2016-04-21 |
Syros Pharmaceuticals, Inc. |
Inhibiteurs de la kinase cycline-dépendante 7 (cdk7)
|
CN117024502A
(zh)
|
2014-10-16 |
2023-11-10 |
萨奇治疗股份有限公司 |
靶向cns障碍的组合物和方法
|
WO2016100711A1
(fr)
|
2014-12-18 |
2016-06-23 |
The Broad Institute, Inc. |
Modulateurs de métabolisme des lipoprotéines hépatiques
|
CN105777632A
(zh)
|
2015-01-09 |
2016-07-20 |
成都贝斯凯瑞生物科技有限公司 |
芳环并氮杂环衍生物及其应用
|
ES2928084T3
(es)
|
2015-02-20 |
2022-11-15 |
Rigel Pharmaceuticals Inc |
Inhibidores de GDF-8
|
EP4212532A3
(fr)
|
2015-04-30 |
2023-09-27 |
Memorial Sloan Kettering Cancer Center |
Analogues de la mitragynine et leurs utilisations
|
CN106083823A
(zh)
|
2015-04-30 |
2016-11-09 |
中国科学院上海药物研究所 |
一类具有激酶抑制活性的化合物、制备方法和用途
|
WO2016183266A1
(fr)
|
2015-05-13 |
2016-11-17 |
Enanta Pharmaceuticals, Inc. |
Agents antiviraux de l'hépatite b
|
LT3319959T
(lt)
|
2015-07-06 |
2021-12-27 |
Alkermes, Inc. |
Histono deacetilazės hetero-halogeno inhibitoriai
|
WO2017007755A1
(fr)
*
|
2015-07-06 |
2017-01-12 |
Rodin Therapeutics, Inc. |
N-aminophényl-amides hétérocycliques en tant qu'inhibiteurs de l'histone désacétylase
|
WO2017027984A1
(fr)
|
2015-08-20 |
2017-02-23 |
Simon Fraser University |
Composés et procédés de traitement anticancéreux par l'inhibition d'atg4b et le blocage de l'autophagie
|
US10980755B2
(en)
|
2015-09-10 |
2021-04-20 |
The Regents Of The University Of California |
LRH-1 modulators
|
EP3362436B1
(fr)
|
2015-09-14 |
2021-06-30 |
Universiteit Antwerpen |
Procédé pour le clivage catalytique dirigé de composés contenant un amide
|
WO2017075694A1
(fr)
|
2015-11-04 |
2017-05-11 |
Simon Fraser University |
Composés antibiotiques, leurs formulations pharmaceutiques, ainsi que procédés associés et utilisations associées
|
TW202246215A
(zh)
|
2015-12-18 |
2022-12-01 |
美商亞德利克斯公司 |
作為非全身tgr5促效劑之經取代之4-苯基吡啶化合物
|
HUE049228T2
(hu)
|
2016-02-23 |
2020-09-28 |
Taiho Pharmaceutical Co Ltd |
Új kondenzált pirimidin vegyület vagy annak sója
|
US11179710B2
(en)
|
2016-03-09 |
2021-11-23 |
President And Fellows Of Harvard College |
Direct palladium-catalyzed aromatic fluorination
|
TWI794171B
(zh)
|
2016-05-11 |
2023-03-01 |
美商滬亞生物國際有限公司 |
Hdac抑制劑與pd-l1抑制劑之組合治療
|
EP3544969A1
(fr)
|
2016-11-23 |
2019-10-02 |
Regenacy Pharmaceuticals, LLC |
Dérivés pipérazine en tant qu'inhibiteurs sélectifs de hdac1,2
|
SG11201906164RA
(en)
|
2017-01-11 |
2019-08-27 |
Rodin Therapeutics Inc |
Bicyclic inhibitors of histone deacetylase
|
CN106946890A
(zh)
|
2017-04-26 |
2017-07-14 |
中国药科大学 |
吡啶类irak4抑制剂、其制备方法及应用
|
JP7152471B2
(ja)
|
2017-08-07 |
2022-10-12 |
ロダン・セラピューティクス,インコーポレーテッド |
ヒストン脱アセチル化酵素の二環阻害剤
|
CN112424184A
(zh)
|
2018-07-13 |
2021-02-26 |
奥克梅斯公司 |
组蛋白脱乙酰酶双环抑制剂
|
SG11202012918PA
(en)
|
2018-07-13 |
2021-02-25 |
Alkermes Inc |
Bicyclic inhibitors of histone deacetylase
|